SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048291
Filing Date
2024-04-25
Accepted
2024-04-25 16:06:10
Documents
5
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A pstx_def_14a_2024.htm DEF 14A 728484
2 GRAPHIC img248980083_0.jpg GRAPHIC 32204
3 GRAPHIC img248980083_1.jpg GRAPHIC 32204
4 GRAPHIC img248980083_2.jpg GRAPHIC 1771939
5 GRAPHIC img248980083_3.jpg GRAPHIC 741100
  Complete submission text file 0000950170-24-048291.txt   3999003
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39376 | Film No.: 24876244
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)